1
|
Hagiwara K, Kitamura H, Tsuchiya Y, Mizoshiri A, Iwabuchi T. 563 CsA-induced hypertrichosis might be caused in part by inhibition of TGF-β2 expression in dermal papilla cells. J Invest Dermatol 2022. [DOI: 10.1016/j.jid.2022.09.579] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
2
|
Kondo M, Hagiwara K, Nukaya A, Aso T, Kanai H. Laparoscopic cholecystectomy using the subserosal layer dissection technique in dogs: 34 cases (2015‐2021). J Small Anim Pract 2022; 64:288-295. [PMID: 36444826 DOI: 10.1111/jsap.13577] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2022] [Revised: 09/27/2022] [Accepted: 10/13/2022] [Indexed: 11/30/2022]
Abstract
OBJECTIVES To describe a standardised subserosal layer dissection technique and evaluate its outcomes in canine laparoscopic cholecystectomy. MATERIALS AND METHODS Medical records of dogs undergoing laparoscopic cholecystectomy using the standardised subserosal layer dissection technique for the treatment of cholecystolithiasis, cholecystitis, and gall bladder mucocele at a single veterinary hospital from January 2015 to September 2021 were extracted. Operative time, subserosal layer dissection achievement rate, open conversion rate, and complication rate were evaluated. RESULTS Thirty-four dogs were included. The most common preoperative diagnosis was cholecystolithiasis (n=29). Operative time was 190 minutes (range: 110 to 330 minutes). Subserosal layer dissection of more than 90% of the gall bladder bed was achieved in 27 (79%) dogs. Conversion to open surgery was required in three (8.8%) dogs. There were no cases of intraoperative bleeding, bile duct injury, or reoperation. CLINICAL SIGNIFICANCE This study showed that laparoscopic cholecystectomy using the standardised subserosal layer dissection technique could be performed successfully in dogs. Future prospective clinical studies are needed to determine safety and effectiveness of this technique compared to standard techniques.
Collapse
Affiliation(s)
- M. Kondo
- Apple Tree Animal Hospital, 52‐2 Hiruta, Takatanacho Anjo‐shi Aichi 446‐0053 Japan
- Laboratory of Veterinary Surgery, Joint Department of Veterinary Medicine, Faculty of Applied Biological Sciences Gifu University, 1‐1 Yanagido, Gifu‐shi Gifu 501‐1193 Japan
| | - K. Hagiwara
- Division of Digestive Surgery, Department of Surgery Nihon University School of Medicine, 1‐6 Kandasurugadai, Chiyoda‐ku Tokyo 101‐8309 Japan
| | - A. Nukaya
- Aya Animal Hospital, 4‐1‐17 Fujinokidai, Nara‐shi Nara 631‐0044 Japan
| | - T. Aso
- Animal Medical Center ALOHA, 5‐12‐5, Hikinocho, Fukuyama‐shi Hiroshima 721‐0942 Japan
| | - H. Kanai
- Kanai Veterinary Surgery, 569‐1 Nozato Himeji‐shi Hyogo 670‐0811 Japan
| |
Collapse
|
3
|
Matsuura R, Maeda K, Hagiwara K, Mori Y, Kitamura T, Matsumoto Y, Aida Y. WO3 Photocatalyst Containing Copper Inactivates SARS-CoV-2 Pango Lineage A and Omicron BA.2 Variant in Visible Light and in Darkness. Pathogens 2022; 11:pathogens11080922. [PMID: 36015043 PMCID: PMC9415178 DOI: 10.3390/pathogens11080922] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2022] [Revised: 08/08/2022] [Accepted: 08/13/2022] [Indexed: 01/14/2023] Open
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease 2019, which has been a global pandemic. Since SARS-CoV-2 is transmitted through contaminated surfaces and aerosols, environmental disinfection is important to block the spread of the virus. Photocatalysts are attractive tools for virus inactivation and are widely used as air purifiers and coating materials. However, photocatalysts are inactive in the dark, and some of them need to be excited with light of a specific wavelength. Therefore, photocatalysts that can effectively inactivate SARS-CoV-2 in indoor environments are needed. Here, we show that a WO3 photocatalyst containing copper inactivated the SARS-CoV-2 WK-521 strain (Pango lineage A) upon irradiation with white light in a time- and concentration-dependent manner. Additionally, this photocatalyst also inactivated SARS-CoV-2 in dark conditions due to the antiviral effect of copper. Furthermore, this photocatalyst inactivated not only the WK-521 strain but also the Omicron variant BA.2. These results indicate that the WO3 photocatalyst containing copper can inactivate indoor SARS-CoV-2 regardless of the variant, in visible light or darkness, making it an effective tool for controlling the spread of SARS-CoV-2.
Collapse
Affiliation(s)
- Ryosuke Matsuura
- Laboratory of Global Infectious Diseases Control Science, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan
- Department of Veterinary Science, National Institute of Infectious Diseases, Toyama, Shinjuku-ku, Tokyo 162-8640, Japan
| | - Ken Maeda
- Department of Veterinary Science, National Institute of Infectious Diseases, Toyama, Shinjuku-ku, Tokyo 162-8640, Japan
| | - Kyoji Hagiwara
- Advintage Co., Ltd., 1-1-1-705 Ebisuminami, Shibuya-ku, Tokyo 150-0022, Japan
| | - Yosuke Mori
- Advintage Co., Ltd., 1-1-1-705 Ebisuminami, Shibuya-ku, Tokyo 150-0022, Japan
| | - Toru Kitamura
- Centre for Advanced Materials and Energy Sciences, Universiti Brunei Darussalam, Gadong BE1410, Brunei
| | - Yasunobu Matsumoto
- Laboratory of Global Infectious Diseases Control Science, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan
- Laboratory of Global Animal Resource Science, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan
| | - Yoko Aida
- Laboratory of Global Infectious Diseases Control Science, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan
- Department of Veterinary Science, National Institute of Infectious Diseases, Toyama, Shinjuku-ku, Tokyo 162-8640, Japan
- Correspondence:
| |
Collapse
|
4
|
Ohka S, Tan SH, Ishiyama E, Ogasawara K, Hanasaka T, Ishida K, Hagiwara K, Liu CC, Chong PCS, Hanaki KI, Schiavo G. The uncoating of EV71 in mature late endosomes requires CD-M6PR. Biol Open 2022; 11:276618. [PMID: 35929543 PMCID: PMC9493940 DOI: 10.1242/bio.059469] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2022] [Accepted: 07/27/2022] [Indexed: 11/20/2022] Open
Abstract
Enterovirus 71 (EV71) is one of the causative agents of hand-foot-and-mouth disease, which in some circumstances could lead to severe neurological diseases. Despite of its importance for human health, little is known about the early stages of EV71 infection. EV71 starts uncoating with its receptor, human scavenger receptor B2 (hSCARB2), at low pH. We show that EV71 was not targeted to lysosomes in human rhabdomyosarcoma cells overexpressing hSCARB2 and that the autophagic pathway is not essential for EV71 productive uncoating. Instead, EV71 was efficiently uncoated 30 minutes after infection in late endosomes (LEs) containing hSCARB2, mannose-6-phosphate receptor (M6PR), RAB9, bis(monoacylglycero)phosphate and lysosomal associated membrane protein 2 (LAMP2). Furthering the notion that mature LEs are crucial for EV71 uncoating, cation-dependent (CD)-M6PR knockdown impairs EV71 infection. Since hSCARB2 interacts with cation-independent (CI)-M6PR through M6P-binding sites and CD-M6PR also harbor a M6P-binding site, CD-M6PR is likely to play important roles in EV71 uncoating in LEs.
Collapse
Affiliation(s)
- Seii Ohka
- Neurovirology Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan
| | - Soon Hao Tan
- Department of Pathology, University of Malaya, Kuala Lumpur, Malaysia
| | - Eri Ishiyama
- Technical Support Center for Life Science Research, Iwate Medical University, Iwate, Japan
| | - Katsutoshi Ogasawara
- Technical Support Center for Life Science Research, Iwate Medical University, Iwate, Japan
| | - Tomohito Hanasaka
- Technical Support Center for Life Science Research, Iwate Medical University, Iwate, Japan
| | - Kinji Ishida
- Technical Support Center for Life Science Research, Iwate Medical University, Iwate, Japan
| | - Kyoji Hagiwara
- Neurovirology Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan
| | - Chia-Chyi Liu
- National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Zhunan Town, Miaoli County, Taiwan
| | - Pele Choi-Sing Chong
- National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Zhunan Town, Miaoli County, Taiwan
| | - Ken-Ichi Hanaki
- Technical Support Center for Life Science Research, Iwate Medical University, Iwate, Japan
| | - Giampietro Schiavo
- Queen Square Institute of Neurology, University College London, London, UK.,UK Dementia Research Institute at UCL, London, UK
| |
Collapse
|
5
|
Kimura M, Yoshimura I, Yanagida K, Yoshida T, Hagiwara K, Kaneko T, Yamada Y, Nakagawa T. Evaluation of ejaculation function using a simple questionnaire. J Sex Med 2022. [DOI: 10.1016/j.jsxm.2022.03.448] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
6
|
Chida S, Sakamoto M, Takino T, Kawamoto S, Hagiwara K. Changes in immune system and intestinal bacteria of cows during the transition period. Vet Anim Sci 2021; 14:100222. [PMID: 34917853 PMCID: PMC8666551 DOI: 10.1016/j.vas.2021.100222] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/27/2021] [Revised: 11/28/2021] [Accepted: 11/29/2021] [Indexed: 11/10/2022] Open
Abstract
Transitional high-energy diets reduce peripheral blood lymphocytes in dairy cows. High-energy diets upregulate IL-1β and IL-2 and downregulate IL-10 expression. Functional lactobacillus plantarum LP1 restores normal levels of lymphocytes subset. Lactobacillus plantarum LP1-added diets reduce inflammatory cytokine expression. LP1 mitigates immune response imbalances caused by transitional high energy diets.
High-yield dairy cows need high energy feed during periods of increased milk production. The transitional feeding to high energy feed increases the risk of developing a variety of metabolic disorders. Here, five Holstein cows were fed a four-stage feeding protocol (3 weeks for each stage) ranging from 54.9 to 73.7% total digestive nutrients (TDN). The purpose of the study was to investigate the effect of lactic acid bacteria on high-energy-fed cows associated with transitional feeding, and to evaluate the effects of probiotics on intestinal bacterial changes and inflammatory responses. Three feed transition periods were established for five cows, and Lactobacillus plantarum RGU-LP1 (LP1) was fed as a probiotic during the high-energy feeding period. The number of lymphocyte subsets such as CD3-, CD4-, and CD8 positive cells decreased in response to the high energy feed. Lipopolysaccharide (LPS)-induced cytokine (IL-1β and IL-2) gene expression in peripheral blood mononuclear cells (PBMCs) was shown to increase in those animals receiving the high energy feed. However, supplementation with LP1 resulted in an increase in the number of lymphocyte subsets and the expression of IL-1β and IL-2 were returned to the level at low energy diet. These results suggest that high energy diets induce inflammatory cytokine responses following LPS stimulation, and that the addition of LP1 mitigates these results by regulating the LPS-induced inflammatory reaction. Therefore, the functional lactic acid bacteria LP1 is expected to regulate inflammation resulting from high energy feeding, and this probiotic could be applied to support inflammatory regulation in high-yield dairy cows.
Collapse
Key Words
- Anti-inflammatories
- CD, cluster of differentiation
- Dairy cows
- EDTA, ethylenediaminetetraacetic acid
- GAPDH, Glyceraldehyde 3-phosphate dehydrogenase
- High-energy feed
- IL, Interleukin
- LPS, Lipopolysaccharide
- Lactobacillus plantarum
- PBMC, peripheral blood mononuclear cell
- Probiotics
- TDN, Total-Digestible-Nutrients
- TGF, Transforming Growth Factor
- TMR, Total-Mixed-Ration
- TNF, Tumor Necrosis Factor
Collapse
Affiliation(s)
- S Chida
- School of veterinary Medicene, Rakuno Gakuen University, 582 Bunkyodai Ebetsu, Hokkaido, 069-8501 Japan
| | - M Sakamoto
- School of veterinary Medicene, Rakuno Gakuen University, 582 Bunkyodai Ebetsu, Hokkaido, 069-8501 Japan
| | - T Takino
- School of veterinary Medicene, Rakuno Gakuen University, 582 Bunkyodai Ebetsu, Hokkaido, 069-8501 Japan.,Scientific Feed Laboratory co., ltd., R & D center, Sakura city, Chiba, 285-0043 Japan
| | - S Kawamoto
- School of veterinary Medicene, Rakuno Gakuen University, 582 Bunkyodai Ebetsu, Hokkaido, 069-8501 Japan
| | - K Hagiwara
- School of veterinary Medicene, Rakuno Gakuen University, 582 Bunkyodai Ebetsu, Hokkaido, 069-8501 Japan
| |
Collapse
|
7
|
Abe K, Bronner C, Hayato Y, Hiraide K, Ikeda M, Imaizumi S, Kameda J, Kanemura Y, Kataoka Y, Miki S, Miura M, Moriyama S, Nagao Y, Nakahata M, Nakayama S, Okada T, Okamoto K, Orii A, Pronost G, Sekiya H, Shiozawa M, Sonoda Y, Suzuki Y, Takeda A, Takemoto Y, Takenaka A, Tanaka H, Watanabe S, Yano T, Han S, Kajita T, Okumura K, Tashiro T, Xia J, Megias G, Bravo-Berguño D, Labarga L, Marti L, Zaldivar B, Pointon B, Blaszczyk F, Kearns E, Raaf J, Stone J, Wan L, Wester T, Bian J, Griskevich N, Kropp W, Locke S, Mine S, Smy M, Sobel H, Takhistov V, Hill J, Kim J, Lim I, Park R, Bodur B, Scholberg K, Walter C, Cao S, Bernard L, Coffani A, Drapier O, El Hedri S, Giampaolo A, Gonin M, Mueller T, Paganini P, Quilain B, Ishizuka T, Nakamura T, Jang J, Learned J, Anthony L, Martin D, Scott M, Sztuc A, Uchida Y, Berardi V, Catanesi M, Radicioni E, Calabria N, Machado L, De Rosa G, Collazuol G, Iacob F, Lamoureux M, Mattiazzi M, Ospina N, Ludovici L, Maekawa Y, Nishimura Y, Friend M, Hasegawa T, Ishida T, Kobayashi T, Jakkapu M, Matsubara T, Nakadaira T, Nakamura K, Oyama Y, Sakashita K, Sekiguchi T, Tsukamoto T, Kotsar Y, Nakano Y, Ozaki H, Shiozawa T, Suzuki A, Takeuchi Y, Yamamoto S, Ali A, Ashida Y, Feng J, Hirota S, Kikawa T, Mori M, Nakaya T, Wendell R, Yasutome K, Fernandez P, McCauley N, Mehta P, Tsui K, Fukuda Y, Itow Y, Menjo H, Niwa T, Sato K, Tsukada M, Lagoda J, Lakshmi S, Mijakowski P, Zalipska J, Jiang J, Jung C, Vilela C, Wilking M, Yanagisawa C, Hagiwara K, Harada M, Horai T, Ishino H, Ito S, Kitagawa H, Koshio Y, Ma W, Piplani N, Sakai S, Barr G, Barrow D, Cook L, Goldsack A, Samani S, Wark D, Nova F, Boschi T, Di Lodovico F, Gao J, Migenda J, Taani M, Zsoldos S, Yang J, Jenkins S, Malek M, McElwee J, Stone O, Thiesse M, Thompson L, Okazawa H, Kim S, Seo J, Yu I, Nishijima K, Koshiba M, Iwamoto K, Nakagiri K, Nakajima Y, Ogawa N, Yokoyama M, Martens K, Vagins M, Kuze M, Izumiyama S, Yoshida T, Inomoto M, Ishitsuka M, Ito H, Kinoshita T, Matsumoto R, Ohta K, Shinoki M, Suganuma T, Ichikawa A, Nakamura K, Martin J, Tanaka H, Towstego T, Akutsu R, Gousy-Leblanc V, Hartz M, Konaka A, de Perio P, Prouse N, Chen S, Xu B, Zhang Y, Posiadala-Zezula M, Hadley D, O’Flaherty M, Richards B, Jamieson B, Walker J, Minamino A, Okamoto K, Pintaudi G, Sano S, Sasaki R. Diffuse supernova neutrino background search at Super-Kamiokande. Int J Clin Exp Med 2021. [DOI: 10.1103/physrevd.104.122002] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
8
|
Ning B, Ren X, Hagiwara K, Takeoka S, Ito Y, Miyatake H. Development of a Non-IgG PD-1/PD-L1 Inhibitor by in Silico Mutagenesis and an In-Cell Protein-Protein Interaction Assay. ACS Chem Biol 2021; 16:316-323. [PMID: 33448787 DOI: 10.1021/acschembio.0c00817] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Inhibiting the programmed death-1 (PD-1)/programmed death ligand 1 (PD-L1) axis by monoclonal antibodies (mAbs) is a successful cancer immunotherapy. However, mAb-based drugs have various disadvantages including high production costs and large molecular sizes, which motivated us to develop a smaller alternative drug. Since PD-L1 binds PD-1 with moderate affinity, a higher affinity PD-1 variant should serve as a competitive inhibitor of the wild-type PD-1/PD-L1 interaction. In this report, we conducted in silico point mutagenesis of PD-1 to identify potent PD-1 variants with a higher affinity toward PD-L1 and refined the in silico results using a luciferase-based in-cell protein-protein interaction (PPI) assay. As a result, a PD-1 variant was developed that had two mutated amino acids (T76Y, A132V), termed 2-PD-1. 2-PD-1 could bind with PD-L1 at a dissociation constant of 12.74 nM. Moreover, 2-PD-1 successfully inhibited the PD-1/PD-L1 interaction with a half maximal inhibitory concentration of 19.15 nM and reactivated the T cell with a half maximal effective concentration of 136.1 nM. These results show that in silico mutagenesis combined with an in-cell PPI assay verification strategy successfully prepared a non-IgG inhibitor of the PD-1/PD-L1 interaction.
Collapse
Affiliation(s)
- Boyang Ning
- Nano Medical Engineering Laboratory, RIKEN Cluster of Pioneering Research, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
- Department of Life Science and Medical Bioscience, Graduate School of Advanced Science and Engineering, Waseda University, TWIns, 2-2 Wakamatsu-cho, Shinjuku-ku, Tokyo 162-8480, Japan
| | - Xueli Ren
- Nano Medical Engineering Laboratory, RIKEN Cluster of Pioneering Research, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - Kyoji Hagiwara
- Nano Medical Engineering Laboratory, RIKEN Cluster of Pioneering Research, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - Shinji Takeoka
- Nano Medical Engineering Laboratory, RIKEN Cluster of Pioneering Research, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
- Department of Life Science and Medical Bioscience, Graduate School of Advanced Science and Engineering, Waseda University, TWIns, 2-2 Wakamatsu-cho, Shinjuku-ku, Tokyo 162-8480, Japan
- Waseda Research Institute for Science and Engineering, Waseda University, 3-4-1 Okubo, Shinjuku-ku, Tokyo 169-8555, Japan
| | - Yoshihiro Ito
- Nano Medical Engineering Laboratory, RIKEN Cluster of Pioneering Research, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
- Department of Life Science and Medical Bioscience, Graduate School of Advanced Science and Engineering, Waseda University, TWIns, 2-2 Wakamatsu-cho, Shinjuku-ku, Tokyo 162-8480, Japan
- Emergent Bioengineering Materials Research Team, RIKEN Center for Emergent Matter Science (CEMS), 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - Hideyuki Miyatake
- Nano Medical Engineering Laboratory, RIKEN Cluster of Pioneering Research, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
- Department of Life Science, Graduate School of Science and Engineering, Saitama University, Saitama city, Saitama 338-8570, Japan
| |
Collapse
|
9
|
Iwabuchi T, Ogura K, Tamba K, Tsunekawa Y, Sugano M, Hagiwara K, Kiso A. Cepharanthine induces the proliferation of human dermal papilla cells and stimulates vascular endothelial growth factor expression through increased intracellular calcium mobilization and hypoxia-inducible factor activation. Clin Exp Dermatol 2021; 46:694-703. [PMID: 33296524 DOI: 10.1111/ced.14533] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2020] [Revised: 11/20/2020] [Accepted: 12/04/2020] [Indexed: 11/26/2022]
Abstract
BACKGROUND Cepharanthine (CEP), a compound extracted from the vine Stephania cephalantha, is commonly prescribed to treat alopecia areata; however, the scientific evidence for its efficacy is limited. AIM To investigate the effect of CEP and its structural analogues on human hair growth in vitro. METHODS The effects of CEP and three of its structural analogues on the proliferation of human dermal papilla cells (hDPCs) and human outer root sheath cells (hORSCs) were investigated. Their effects on vascular endothelial growth factor (VEGF) expression were also assessed by real-time PCR. Activation of pathways leading to VEGF expression, such as intracellular Ca2+ mobilization and hypoxia-inducible factor (HIF) expression, was also characterized. RESULTS CEP and two of its structural analogues significantly stimulated the growth of hDPCs but not hORSCs. Moreover, CEP and all three structural analogues significantly induced the expression of VEGF in hDPCs. CEP increased the intracellular Ca2+ concentration in hDPCs. CEP also increased the expression of HIF-1α and HIF-2α and induced the expression of HIF-responsive genes in hDPCs, even under normoxia. CONCLUSIONS These results suggest that CEP and its structural analogues have the potential to restore hair growth by promoting the proliferation of hDPCs and increasing their expression of VEGF.
Collapse
Affiliation(s)
- T Iwabuchi
- Faculty of Bioscience and Biotechnology, Tokyo University of Technology, Hachioji, Tokyo, Japan
| | - K Ogura
- Faculty of Bioscience and Biotechnology, Tokyo University of Technology, Hachioji, Tokyo, Japan
| | - K Tamba
- Faculty of Bioscience and Biotechnology, Tokyo University of Technology, Hachioji, Tokyo, Japan
| | - Y Tsunekawa
- Faculty of Bioscience and Biotechnology, Tokyo University of Technology, Hachioji, Tokyo, Japan
| | - M Sugano
- Faculty of Bioscience and Biotechnology, Tokyo University of Technology, Hachioji, Tokyo, Japan
| | - K Hagiwara
- Faculty of Bioscience and Biotechnology, Tokyo University of Technology, Hachioji, Tokyo, Japan
| | - A Kiso
- Research Center, Maruzen Pharmaceuticals Co. Ltd., Fukuyama, Hiroshima, Japan
| |
Collapse
|
10
|
Abe K, Bronner C, Hayato Y, Ikeda M, Imaizumi S, Ito H, Kameda J, Kataoka Y, Miura M, Moriyama S, Nagao Y, Nakahata M, Nakajima Y, Nakayama S, Okada T, Okamoto K, Orii A, Pronost G, Sekiya H, Shiozawa M, Sonoda Y, Suzuki Y, Takeda A, Takemoto Y, Takenaka A, Tanaka H, Yano T, Akutsu R, Han S, Kajita T, Okumura K, Tashiro T, Wang R, Xia J, Bravo-Berguño D, Labarga L, Marti L, Zaldivar B, Blaszczyk F, Kearns E, Gustafson J, Raaf J, Stone J, Wan L, Wester T, Bian J, Griskevich N, Kropp W, Locke S, Mine S, Smy M, Sobel H, Takhistov V, Weatherly P, Hill J, Kim J, Lim I, Park R, Bodur B, Scholberg K, Walter C, Coffani A, Drapier O, El Hedri S, Giampaolo A, Gonin M, Mueller T, Paganini P, Quilain B, Ishizuka T, Nakamura T, Jang J, Learned J, Anthony L, Sztuc A, Uchida Y, Berardi V, Catanesi M, Radicioni E, Calabria N, Machado L, De Rosa G, Collazuol G, Iacob F, Lamoureux M, Ospina N, Ludovici L, Nishimura Y, Cao S, Friend M, Hasegawa T, Ishida T, Kobayashi T, Matsubara T, Nakadaira T, Jakkapu M, Nakamura K, Oyama Y, Sakashita K, Sekiguchi T, Tsukamoto T, Nakano Y, Shiozawa T, Suzuki A, Takeuchi Y, Yamamoto S, Ali A, Ashida Y, Feng J, Hirota S, Ichikawa A, Kikawa T, Mori M, Nakaya T, Wendell R, Yasutome K, Fernandez P, McCauley N, Mehta P, Pritchard A, Tsui K, Fukuda Y, Itow Y, Menjo H, Niwa T, Sato K, Tsukada M, Mijakowski P, Posiadala-Zezula M, Jung C, Vilela C, Wilking M, Yanagisawa C, Harada M, Hagiwara K, Horai T, Ishino H, Ito S, Koshio Y, Ma W, Piplani N, Sakai S, Kuno Y, Barr G, Barrow D, Cook L, Goldsack A, Samani S, Simpson C, Wark D, Nova F, Boschi T, Di Lodovico F, Molina Sedgwick S, Taani M, Zsoldos S, Yang J, Jenkins S, McElwee J, Thiesse M, Thompson L, Malek M, Stone O, Okazawa H, Kim S, Yu I, Nishijima K, Koshiba M, Ogawa N, Iwamoto K, Yokoyama M, Martens K, Vagins M, Kuze M, Izumiyama S, Tanaka M, Yoshida T, Inomoto M, Ishitsuka M, Matsumoto R, Ohta K, Shinoki M, Martin J, Tanaka H, Towstego T, Hartz M, Konaka A, de Perio P, Prouse N, Pointon B, Chen S, Xu B, Richards B, Jamieson B, Walker J, Minamino A, Okamoto K, Pintaudi G, Sasaki R. Neutron-antineutron oscillation search using a 0.37 megaton-years exposure of Super-Kamiokande. Int J Clin Exp Med 2021. [DOI: 10.1103/physrevd.103.012008] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
11
|
Hachisuka M, Hayashi H, Mimuro R, Maru Y, Fujimoto Y, Oka E, Hagiwara K, Tsuboi I, Yamamoto T, Yodogawa K, Iwasaki Y, Ogano M, Hayashi M, Shimizu W. P1032Efficacy and safety of radiofrequency catheter ablation for atrial fibrillation in patients undergoing hemodaialysis. Eur Heart J 2019. [DOI: 10.1093/eurheartj/ehz747.0623] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Introduction
Although radiofrequency catheter ablation (RFCA) for atrial fibrillation (AF) has become a standard therapy, the ablation outcomes in patients undergoing hemodialysis (HD) has not been fully elucidated. The present study aimed to evaluate the clinical outcomes of RFCA for AF in patients undergoing HD.
Methods
Twenty-three patients undergoing HD (17 men, age 65±8 years, 19 paroxysmal AF) who underwent RFCA for drug-refractory AF in two institutes were enrolled in the study and defined as HD group. The clinical parameters, recurrence free rate and frequency of periprocedural complications were compared to 46 randomly selected age, gender and left atrial diameter matched controls not requiring HD defined as non-HD group (34men, age 67±7 years, 38 paroxysmal AF).
Results
The patients in HD group had a significantly lower body mass index (21±3 vs. 25±3 P<0.01), higher prevalence of coronary artery disease (30% vs. 10% P=0.04), and higher prevalence of congestive heart failure (52% vs. 10% P<0.01) compared to patients in non-HD group. Echocardiography indicated lower left ventricular ejection fraction (57±17% vs. 65±9% P=0.02), higher E/e' (20±8 vs. 12±4 P<0.01), higher tricuspid regurgitation pressure gradient (30mmHg vs. 24mmHg P<0.01) and more impaired left ventricular diastolic function in HD group. All the subjects underwent bilateral pulmonary vein isolation plus additional linear lesion. The number of ablation procedure was similar between the two groups (1.43±0.5 vs. 1.46±0.6 P=0.88). During the follow-up period of 37±25 months after the last procedure, the arrhythmia free rate was similar between the two groups (86% vs. 84% log-rank P=0.82). Vascular access complication occurred in two patients in HD group, and pericardial effusion occurred in one patient in non-HD group, while no life-threatening complications were observed in either group. Cardiogenic cerebral infarction occurred in one patient in non-HD group. Discontinuation of oral anticoagulation after the ablation was more often seen in the HD group compared to non-HD group (91% vs. 60% P<0.01).
Conclusions
Although patients undergoing HD had more impaired left ventricular systolic and diastolic function, RFCA for AF in patients with HD was shown to be as effective and safe as in non-HD patients. RFCA may be an efficient approach to manage AF in patients undergoing HD.
Collapse
Affiliation(s)
| | | | - R Mimuro
- Nippon Medical School, Tokyo, Japan
| | - Y Maru
- Nippon Medical School, Tokyo, Japan
| | | | - E Oka
- Nippon Medical School, Tokyo, Japan
| | | | - I Tsuboi
- Shizuoka Medical Center, Shizuoka, Japan
| | | | | | | | - M Ogano
- Shizuoka Medical Center, Shizuoka, Japan
| | | | | |
Collapse
|
12
|
Matsumoto M, Hagiwara K, Komuro H, Miyamoto Y, Yamamoto H, Shirahashi K, Doi K, Iwata H. P1.17-41 Preoperative Prognostic Nutritional Index (PNI) as a Prognostic Factor in Patients with Clinical Stage I Non-Small-Cell Lung Cancer. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.1314] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
13
|
Isnard J, Hagiwara K, Montavont A, Catenoix H, Mazzola L, Ostrowsky-Coste K, Guenot M, Rheims S. Semiology of insular lobe seizures. Rev Neurol (Paris) 2019; 175:144-149. [DOI: 10.1016/j.neurol.2018.12.002] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2018] [Revised: 11/12/2018] [Accepted: 12/07/2018] [Indexed: 12/22/2022]
|
14
|
Garcia-Larrea L, Hagiwara K. Electrophysiology in diagnosis and management of neuropathic pain. Rev Neurol (Paris) 2019; 175:26-37. [DOI: 10.1016/j.neurol.2018.09.015] [Citation(s) in RCA: 21] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2018] [Accepted: 09/24/2018] [Indexed: 12/30/2022]
|
15
|
Kawashima Y, Fukuhara T, Furuya N, Saito H, Watanabe K, Iwasawa S, Tsunezuka Y, Yamaguchi O, Okada M, Yoshimori K, Nakachi I, Gemma A, Azuma K, Hagiwara K, Nukiwa T, Morita S, Kobayashi K, Maemondo M. Phase III study comparing bevacizumab plus erlotinib (BE) to erlotinib (E) in patients (pts) with untreated NSCLC harboring EGFR mutations: NEJ026. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy292.063] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
16
|
Uchiyama A, Nagai Y, Takigami A, Sata M, Hagiwara K. P2.12-09 Efficacy and Safety of Carboplatin and Paclitaxel for Patients Preexisting Interstitial Lung Disease with Small Cell Lung Cancer. J Thorac Oncol 2018. [DOI: 10.1016/j.jtho.2018.08.1385] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
17
|
Affiliation(s)
- Y Suyama
- Division of Rheumatology, JR Tokyo General Hospital, 2-1-3 Yoyogi Shibuya-Ku, Tokyo 151-8528, Japan and Immuno-Rheumatology Center, St. Luke's International Hospital, St. Luke's International University, 9-1 Akashi-cho Chuo-Ku, Tokyo 104-8560, Japan
| | - R Ikeda
- Department of Neurosurgery, JR Tokyo General Hospital, 2-1-3 Yoyogi Shibuya-Ku, Tokyo, 151-8528, Japan
| | - S Tanaka
- Department of Pathology, JR Tokyo General Hospital, 2-1-3 Yoyogi Shibuya-Ku, Tokyo, 151-8528, Japan
| | - K Hagiwara
- Division of Rheumatology, JR Tokyo General Hospital, 2-1-3 Yoyogi Shibuya-Ku, Tokyo, 151-8528, Japan
| |
Collapse
|
18
|
Noro R, Kobayashi K, Usuki J, Hosomi Y, Nishitsuji M, Okamoto H, Ando M, Hino M, Hagiwara K, Miyanaga A, Seike M, Kubota K, Gemma A. Phase II study of efficacy of bevacizumab plus chemotherapy in management of malignant pleural effusion in non-squamous non-small cell lung cancer patients with malignant pleural effusion (MPE) unsuccessfully controlled by tube drainage or pleurodesis (NEJ-13-2 trial). Ann Oncol 2017. [DOI: 10.1093/annonc/mdx671.034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
19
|
Fukuhara T, Oizumi S, Sugawara S, Minato K, Harada T, Inoue A, Fujita Y, Watanabe S, Ito K, Gemma A, Demura Y, Harada M, Isobe H, Kinoshita I, Morita S, Kobayashi K, Hagiwara K, Kurihara M, Nukiwa T. P2.03-010 Updated Survival Outcomes of NEJ005/TCOG0902, a Randomized PII of Gefitinib and Chemotherapy in EGFR-Mutant NSCLC. J Thorac Oncol 2017. [DOI: 10.1016/j.jtho.2017.09.1261] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
20
|
Hagiwara K, Michishita M, Yoshimura H, Ochiai K, Azakami D, Ishiwata T, Takahashi K. Pancreatic Colloid Carcinoma in an Elderly Cat. J Comp Pathol 2017; 157:266-269. [DOI: 10.1016/j.jcpa.2017.08.006] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2017] [Revised: 08/21/2017] [Accepted: 08/30/2017] [Indexed: 11/17/2022]
|
21
|
Suzuki T, Hagiwara K, Suzuki K. Conservative treatment for isolated ulnar neck fractures with early motion of the forearm in a cast. J Hand Surg Eur Vol 2017; 42:752-753. [PMID: 28486868 DOI: 10.1177/1753193416678347] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Affiliation(s)
- T Suzuki
- 1 Department of Orthopaedic Surgery, Fujita Health University, Toyoake, Japan.,2 Department of Orthopaedic Surgery, Keio University School of Medicine, Shinjuku, Japan
| | - K Hagiwara
- 2 Department of Orthopaedic Surgery, Keio University School of Medicine, Shinjuku, Japan
| | - K Suzuki
- 1 Department of Orthopaedic Surgery, Fujita Health University, Toyoake, Japan
| |
Collapse
|
22
|
Nair BG, Zhou Y, Hagiwara K, Ueki M, Isoshima T, Abe H, Ito Y. Enhancement of synergistic gene silencing by RNA interference using branched “3-in-1” trimer siRNA. J Mater Chem B 2017; 5:4044-4051. [DOI: 10.1039/c7tb00846e] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Nanostructured RNA carrying three different siRNAs was assembled to silence three target genes (Axin, APC, and GSK-3β) in the Wnt/β-catenin signaling pathway. This nanostructured ‘3-in-1’ siRNA showed high activity at a low concentration due to the long-term resistance, and enhancing the effect of RNA interference.
Collapse
Affiliation(s)
| | - Yue Zhou
- Nano Medical Engineering Laboratory
- RIKEN
- Wako
- Japan
| | - Kyoji Hagiwara
- Emergent Bioengineering Materials Research Team
- RIKEN Center for Emergent Matter Science
- Wako
- Japan
| | - Masashi Ueki
- Nano Medical Engineering Laboratory
- RIKEN
- Wako
- Japan
| | | | - Hiroshi Abe
- Nano Medical Engineering Laboratory
- RIKEN
- Wako
- Japan
- Emergent Bioengineering Materials Research Team
| | - Yoshihiro Ito
- Nano Medical Engineering Laboratory
- RIKEN
- Wako
- Japan
- Emergent Bioengineering Materials Research Team
| |
Collapse
|
23
|
Yoneyama T, Tanaka T, Narita T, Oikawa M, Hagiwara K, Yoneyama T, Imai A, Hatakeyama S, Hashimoto Y, Koie T, Ohyama C. 278P Sequential chemotherapy with gemcitabine plus carboplatin, followed by additional docetaxel for advanced upper-tract urothelial cancer patient with impaired renal function. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw583.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
24
|
Yoneyama T, Tanaka T, Narita T, Oikawa M, Hagiwara K, Yoneyama T. 278P Sequential chemotherapy with gemcitabine plus carboplatin, followed by additional docetaxel for advanced upper-tract urothelial cancer patient with impaired renal function. Ann Oncol 2016. [DOI: 10.1016/s0923-7534(21)00435-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
25
|
Maemondo M, Fukuhara T, Sugawara S, Takiguchi Y, Inoue A, Oizumi S, Ishii Y, Yoshizawa H, Isobe T, Gemma A, Morita S, Hagiwara K, Kobayashi K, Nukiwa T. NEJ026: Phase III study comparing bevacizumab plus erlotinib to erlotinib in patients with untreated NSCLC harboring activating EGFR mutations. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw383.86] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
26
|
Makino A, Abe M, Ishitsuka R, Murate M, Kishimoto T, Sakai S, Hullin-Matsuda F, Shimada Y, Inaba T, Miyatake H, Tanaka H, Kurahashi A, Pack CG, Kasai RS, Kubo S, Schieber NL, Dohmae N, Tochio N, Hagiwara K, Sasaki Y, Aida Y, Fujimori F, Kigawa T, Nishibori K, Parton RG, Kusumi A, Sako Y, Anderluh G, Yamashita M, Kobayashi T, Greimel P, Kobayashi T. A novel sphingomyelin/cholesterol domain-specific probe reveals the dynamics of the membrane domains during virus release and in Niemann-Pick type C. FASEB J 2016; 31:1301-1322. [PMID: 27492925 DOI: 10.1096/fj.201500075r] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2016] [Accepted: 07/18/2016] [Indexed: 01/07/2023]
Abstract
We identified a novel, nontoxic mushroom protein that specifically binds to a complex of sphingomyelin (SM), a major sphingolipid in mammalian cells, and cholesterol (Chol). The purified protein, termed nakanori, labeled cell surface domains in an SM- and Chol-dependent manner and decorated specific lipid domains that colocalized with inner leaflet small GTPase H-Ras, but not K-Ras. The use of nakanori as a lipid-domain-specific probe revealed altered distribution and dynamics of SM/Chol on the cell surface of Niemann-Pick type C fibroblasts, possibly explaining some of the disease phenotype. In addition, that nakanori treatment of epithelial cells after influenza virus infection potently inhibited virus release demonstrates the therapeutic value of targeting specific lipid domains for anti-viral treatment.-Makino, A., Abe, M., Ishitsuka, R., Murate, M., Kishimoto, T., Sakai, S., Hullin-Matsuda, F., Shimada, Y., Inaba, T., Miyatake, H., Tanaka, H., Kurahashi, A., Pack, C.-G., Kasai, R. S., Kubo, S., Schieber, N. L., Dohmae, N., Tochio, N., Hagiwara, K., Sasaki, Y., Aida, Y., Fujimori, F., Kigawa, T., Nishibori, K., Parton, R. G., Kusumi, A., Sako, Y., Anderluh, G., Yamashita, M., Kobayashi, T., Greimel, P., Kobayashi, T. A novel sphingomyelin/cholesterol domain-specific probe reveals the dynamics of the membrane domains during virus release and in Niemann-Pick type C.
Collapse
Affiliation(s)
| | | | | | | | | | | | - Françoise Hullin-Matsuda
- Rikagaku Kenkyūsho (RIKEN), Saitama, Japan.,Université Lyon 1, INSERM, Unité 1060, Villeurbanne, France
| | | | | | | | - Hideko Tanaka
- Faculty of Core Research, Natural Science Division, Ochanomizu University, Tokyo, Japan
| | | | | | - Rinshi S Kasai
- Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan
| | - Shuku Kubo
- Daiichi Sankyo Co., Limited, Tokyo, Japan
| | - Nicole L Schieber
- Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland, Australia
| | | | | | | | | | - Yoko Aida
- Rikagaku Kenkyūsho (RIKEN), Saitama, Japan
| | - Fumihiro Fujimori
- Graduate School of Humanities and Life Sciences, Tokyo Kasei University, Tokyo, Japan
| | | | | | - Robert G Parton
- Institute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland, Australia.,Centre for Microscopy and Microanalysis, The University of Queensland, St. Lucia, Queensland, Australia
| | - Akihiro Kusumi
- Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan.,Institute for Integrated Cell-Material Sciences (WPI-iCeMS), Kyoto University, Kyoto, Japan
| | | | - Gregor Anderluh
- National Institute of Chemistry, Ljubljana, Slovenia.,Department of Biology, Biotechnical Faculty, University of Ljubljana, Ljubljana, Slovenia; and
| | | | - Tetsuyuki Kobayashi
- Faculty of Core Research, Natural Science Division, Ochanomizu University, Tokyo, Japan
| | | | - Toshihide Kobayashi
- Rikagaku Kenkyūsho (RIKEN), Saitama, Japan; .,Unité Mixte de Recherche 7213, Centre National de la Recherche Scientifique, Université de Strasbourg, Illkirch, France
| |
Collapse
|
27
|
Nair BG, Hagiwara K, Ueda M, Yu HH, Tseng HR, Ito Y. High Density of Aligned Nanowire Treated with Polydopamine for Efficient Gene Silencing by siRNA According to Cell Membrane Perturbation. ACS Appl Mater Interfaces 2016; 8:18693-18700. [PMID: 27420034 DOI: 10.1021/acsami.6b04913] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Abstract
High aspect ratio nanomaterials, such as vertically aligned silicon nanowire (SiNW) substrates, are three-dimensional topological features for cell manipulations. A high density of SiNWs significantly affects not only cell adhesion and proliferation but also the delivery of biomolecules to cells. Here, we used polydopamine (PD) that simply formed a thin coating on various material surfaces by the action of dopamine as a bioinspired approach. The PD coating not only enhanced cell adhesion, spreading, and growth but also anchored more siRNA by adsorption and provided more surface concentration for substrate-mediated delivery. By comparing plain and SiNW surfaces with the same amount of loaded siRNA, we quantitatively found that PD coating efficiently anchored siRNA on the surface, which knocked down the expression of a specific gene by RNA interference. It was also found that the interaction of SiNWs with the cell membrane perturbed the lateral diffusion of lipids in the membrane by fluorescence recovery after photobleaching. The perturbation was considered to induce the effective delivery of siRNA into cells and allow the cells to carry out their biological functions. These results suggest promising applications of PD-coated, high-density SiNWs as simple, fast, and versatile platforms for transmembrane delivery of biomolecules.
Collapse
Affiliation(s)
- Baiju G Nair
- Nano Medical Engineering Laboratory, RIKEN , 2-1 Hirosawa, Wako, Saitama 3510198, Japan
| | - Kyoji Hagiwara
- Emergent Bioengineering Material Research Team, RIKEN Centre for Emergent Matter Science , 2-1 Hirosawa, Wako, Saitama 3510198, Japan
- Laboratory of Human Science and Engineering , 1-3-1 Minaminagasaki, Toshima-ku, Tokyo 1710052, Japan
| | - Motoki Ueda
- Nano Medical Engineering Laboratory, RIKEN , 2-1 Hirosawa, Wako, Saitama 3510198, Japan
- Emergent Bioengineering Material Research Team, RIKEN Centre for Emergent Matter Science , 2-1 Hirosawa, Wako, Saitama 3510198, Japan
| | - Hsiao-Hua Yu
- Nano Medical Engineering Laboratory, RIKEN , 2-1 Hirosawa, Wako, Saitama 3510198, Japan
- Institute of Chemistry, Academia Sinica , 128 Academia Road Sec. 2, Nankang, Taipei 115, Taiwan
| | - Hsian-Rong Tseng
- Department of Molecular and Medical Pharmacology, University of California , Los Angeles CNSI, 570 Westwood Plaza, Los Angeles, California 90095, United States
| | - Yoshihiro Ito
- Nano Medical Engineering Laboratory, RIKEN , 2-1 Hirosawa, Wako, Saitama 3510198, Japan
- Emergent Bioengineering Material Research Team, RIKEN Centre for Emergent Matter Science , 2-1 Hirosawa, Wako, Saitama 3510198, Japan
| |
Collapse
|
28
|
Minagi T, Okamoto H, Ikegawa M, Ideno S, Takahashi K, Sakai K, Hagiwara K, Yunoki M, Wakisaka A. Hepatitis E virus in donor plasma collected in Japan. Vox Sang 2016; 111:242-246. [DOI: 10.1111/vox.12425] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2016] [Revised: 05/17/2016] [Accepted: 05/17/2016] [Indexed: 01/18/2023]
Affiliation(s)
- T. Minagi
- Quality Control; Kyoto Plant; Japan Blood Products Organization; Kyoto Japan
| | - H. Okamoto
- Quality Control; Kyoto Plant; Japan Blood Products Organization; Kyoto Japan
| | - M. Ikegawa
- Quality Control; Kyoto Plant; Japan Blood Products Organization; Kyoto Japan
| | - S. Ideno
- R & D Division; Japan Blood Products Organization; Tokyo Japan
| | - K. Takahashi
- R & D Division; Japan Blood Products Organization; Tokyo Japan
| | - K. Sakai
- R & D Division; Japan Blood Products Organization; Tokyo Japan
| | - K. Hagiwara
- Graduate School of Veterinary Medicine; Rakuno Gakuen University; Ebetsu Hokkaido Japan
| | - M. Yunoki
- R & D Division; Japan Blood Products Organization; Tokyo Japan
- Graduate School of Veterinary Medicine; Rakuno Gakuen University; Ebetsu Hokkaido Japan
| | - A. Wakisaka
- R & D Division; Japan Blood Products Organization; Tokyo Japan
| |
Collapse
|
29
|
Miyatake H, Sanjoh A, Murakami T, Murakami H, Matsuda G, Hagiwara K, Yokoyama M, Sato H, Miyamoto Y, Dohmae N, Aida Y. Molecular Mechanism of HIV-1 Vpr for Binding to Importin-α. J Mol Biol 2016; 428:2744-57. [PMID: 27181198 DOI: 10.1016/j.jmb.2016.05.003] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2015] [Revised: 05/03/2016] [Accepted: 05/03/2016] [Indexed: 02/06/2023]
Abstract
Viral protein R (Vpr) is an accessory gene product of human immunodeficiency virus type 1 (HIV-1) that plays multiple important roles associated with viral replication. Structural studies using NMR have revealed that Vpr consists of three α-helices and contains flexible N- and C-termini. However, the molecular mechanisms associated with Vpr function have not been elucidated. To investigate Vpr multifunctionality, we performed an X-ray crystallographic study of Vpr complexes containing importin-α, a known Vpr binding partner present in host cells. Elucidation of the crystal structure revealed that the flexible C-terminus changes its conformation to a twisted β-turn via an induced-fit mechanism, enabling binding to a minor nuclear localization signal (NLS) site of importin-α. The Vpr C-terminus can also bind with major NLS sites of importin-α in an extended conformation in different ways. These results, which represent the first reported crystallographic analysis of Vpr, demonstrate the multifunctional aspects that enable Vpr interaction with a variety of cellular proteins.
Collapse
Affiliation(s)
- Hideyuki Miyatake
- Nano Medical Engineering Laboratory, RIKEN, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan.
| | - Akira Sanjoh
- Protein Wave Corporation, 1-16-5 Nishitomigaoka, Nara 631-0006, Japan
| | - Tomoyuki Murakami
- Viral Infectious Diseases Unit, RIKEN, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan
| | - Hironobu Murakami
- Viral Infectious Diseases Unit, RIKEN, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan
| | - Go Matsuda
- Viral Infectious Diseases Unit, RIKEN, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan
| | - Kyoji Hagiwara
- Viral Infectious Diseases Unit, RIKEN, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan
| | - Masaru Yokoyama
- Laboratory of Viral Genomics, Pathogen Genomics Center, National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashimurayama, Tokyo 208-0011, Japan
| | - Hironori Sato
- Laboratory of Viral Genomics, Pathogen Genomics Center, National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashimurayama, Tokyo 208-0011, Japan
| | - Yoichi Miyamoto
- Laboratory of Nuclear Transport Dynamics, National Institute of Biomedical Innovation, 7-6-8 Saito-Asagi, Ibaraki-shi, Osaka, 567-0085, Japan
| | - Naoshi Dohmae
- Center for Sustainable Resource Science, RIKEN, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan
| | - Yoko Aida
- Viral Infectious Diseases Unit, RIKEN, 2-1 Hirosawa, Wako-shi, Saitama 351-0198, Japan.
| |
Collapse
|
30
|
Han B, Ratcliffe M, Haddad V, Brown H, Tjulandin S, Hagiwara K, Reck M, Normanno N. 59PD Association of EGFR mutation subtypes with clinical and demographic characteristics of patients (pts) with aNSCLC: IGNITE and ASSESS pooled analysis. J Thorac Oncol 2016. [DOI: 10.1016/s1556-0864(16)30172-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
31
|
Normanno N, Brown H, Haddad V, Ratcliffe M, McCormack R, Tjulandin S, Hagiwara K, Han B, Reck M. 580_PR: Clinical and demographic features that influence EGFR mutation detection in plasma from patients (pts) with aNSCLC: The ASSESS experience. J Thorac Oncol 2016. [DOI: 10.1016/s1556-0864(16)30323-9] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
32
|
Hagiwara K, Perchet C, Bastuji H, Garcia-Larrea L. ID 213 – Comparative study between intra-epidermal electric stimulation and laser stimulation for C-fiber activation. Do we stimulate the same C-fibers? Clin Neurophysiol 2016. [DOI: 10.1016/j.clinph.2015.11.390] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
33
|
Hagiwara K, Ishii H, Murakami T, Takeshima SN, Chutiwitoonchai N, Kodama EN, Kawaji K, Kondoh Y, Honda K, Osada H, Tsunetsugu-Yokota Y, Suzuki M, Aida Y. Synthesis of a Vpr-Binding Derivative for Use as a Novel HIV-1 Inhibitor. PLoS One 2015; 10:e0145573. [PMID: 26701275 PMCID: PMC4689350 DOI: 10.1371/journal.pone.0145573] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2015] [Accepted: 12/04/2015] [Indexed: 01/18/2023] Open
Abstract
The emergence of multidrug-resistant viruses compromises the efficacy of anti-human immunodeficiency virus type 1 (HIV-1) therapy and limits treatment options. Therefore, new targets that can be used to develop novel antiviral agents need to be identified. We previously identified a potential parent compound, hematoxylin, which suppresses the nuclear import of HIV-1 via the Vpr-importin α interaction and inhibits HIV-1 replication in a Vpr-dependent manner by blocking nuclear import of the pre-integration complex. However, it was unstable. Here, we synthesized a stable derivative of hematoxylin that bound specifically and stably to Vpr and inhibited HIV-1 replication in macrophages. Furthermore, like hematoxylin, the derivative inhibited nuclear import of Vpr in an in vitro nuclear import assay, but had no effect on Vpr-induced G2/M phase cell cycle arrest or caspase activity. Interestingly, this derivative bound strongly to amino acid residues 54–74 within the C-terminal α-helical domain (αH3) of Vpr. These residues are highly conserved among different HIV strains, indicating that this region is a potential target for drug-resistant HIV-1 infection. Thus, we succeeded in developing a stable hematoxylin derivative that bound directly to Vpr, suggesting that specific inhibitors of the interaction between cells and viral accessory proteins may provide a new strategy for the treatment of HIV-1 infection.
Collapse
Affiliation(s)
- Kyoji Hagiwara
- Viral Infectious Diseases Unit, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - Hideki Ishii
- Molecular Imaging Medicinal Chemistry Laboratory, RIKEN Center for Molecular Imaging Science, 6-7-3 Minatoshima-minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan
| | - Tomoyuki Murakami
- Viral Infectious Diseases Unit, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | | | | | - Eiichi N Kodama
- Division of Miyagi Community Health Promotion, Tohoku University Graduate School of Medicine, 2-1 Seiryocho, Aoba-ku, Sendai 980-8575, Japan
| | - Kumi Kawaji
- Division of Miyagi Community Health Promotion, Tohoku University Graduate School of Medicine, 2-1 Seiryocho, Aoba-ku, Sendai 980-8575, Japan
| | - Yasumitsu Kondoh
- Chemical Biology Research Group, RIKEN CSRS, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - Kaori Honda
- Chemical Biology Research Group, RIKEN CSRS, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - Hiroyuki Osada
- Chemical Biology Research Group, RIKEN CSRS, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - Yasuko Tsunetsugu-Yokota
- Department of Frontier Biosciences, Department of Immunology, National Institute of Infectious Diseases, Toyama, Shinjuku-ku, Tokyo 162-8640, Japan
| | - Masaaki Suzuki
- Molecular Imaging Medicinal Chemistry Laboratory, RIKEN Center for Molecular Imaging Science, 6-7-3 Minatoshima-minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan
| | - Yoko Aida
- Viral Infectious Diseases Unit, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| |
Collapse
|
34
|
Ackermann M, Albert A, Baldini L, Ballet J, Barbiellini G, Barbieri C, Bastieri D, Bellazzini R, Bissaldi E, Bonino R, Bottacini E, Brandt TJ, Bregeon J, Bruel P, Buehler R, Caliandro GA, Cameron RA, Caraveo PA, Cecchi C, Charles E, Chekhtman A, Cheung CC, Chiang J, Chiaro G, Ciprini S, Cohen-Tanugi J, Cuoco A, Cutini S, D’Ammando F, Desiante FDPR, Digel SW, Di Venere L, Drell PS, Favuzzi C, Fegan SJ, Ferrara EC, Franckowiak A, Funk S, Fusco P, Gargano F, Gasparrini D, Giglietto N, Giordano F, Godfrey G, Grenier IA, Grondin MH, Grove JE, Guillemot L, Guiriec S, Hagiwara K, Harding AK, Hays E, Hewitt JW, Hill AB, Horan D, Johnson TJ, Knödlseder J, Kuss M, Larsson S, Latronico L, Lemoine-Goumard M, Li J, Li L, Longo F, Loparco F, Lovellette MN, Lubrano P, Maldera S, Manfreda A, Marshall F, Martin P, Mayer M, Mazziotta MN, Michelson PF, Mirabal N, Mizuno T, Monzani ME, Morselli A, Moskalenko IV, Murgia S, Naletto G, Nuss E, Ohsugi T, Orienti M, Orlando E, Paneque D, Pesce-Rollins M, Piron F, Pivato G, Porter TA, Rainò S, Rando R, Razzano M, Reimer A, Reimer O, Reposeur T, Romani RW, Parkinson PMS, Schulz A, Sgrò C, Siskind EJ, Smith DA, Spada F, Spandre G, Spinelli P, Suson DJ, Takahashi H, Thayer JB, Thompson DJ, Tibaldo L, Torres DF, Uchiyama Y, Vianello G, Wood KS, Wood M, Zampieri L. An extremely bright gamma-ray pulsar in the Large Magellanic Cloud. Science 2015; 350:801-5. [DOI: 10.1126/science.aac7400] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
|
35
|
He P, Hagiwara K, Chong H, Yu HH, Ito Y. Low-Molecular-Weight Polyethyleneimine Grafted Polythiophene for Efficient siRNA Delivery. Biomed Res Int 2015; 2015:406389. [PMID: 26539490 PMCID: PMC4619845 DOI: 10.1155/2015/406389] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/04/2015] [Revised: 06/13/2015] [Accepted: 06/23/2015] [Indexed: 01/29/2023]
Abstract
Owing to its hydrophilicity, negative charge, small size, and labile degradation by endogenous nucleases, small interfering RNA (siRNA) delivery must be achieved by a carrier system. In this study, cationic copolymers composed of low-molecular-weight polyethylenimine and polythiophenes were synthesized and evaluated as novel self-tracking siRNA delivery vectors. The concept underlying the design of these copolymers is that hydrophobicity and rigidity of polythiophenes should enhance the transport of siRNA across the cell membrane and endosomal membrane. A gel retardation assay showed that the nanosized complexes formed between the copolymers and siRNA were stable even at a molar ratio of 1 : 2. The high cellular uptake (>80%) and localization of the copolymer vectors inside the cells were easily analyzed by tracking the fluorescence of polythiophene using fluorescent microscopy and cytometry. An in vitro luciferase knockdown (KD) assay in A549-luc cells demonstrated that the siRNA complexes with more hydrophobic copolymers achieved a higher KD efficiency of 52.8% without notable cytotoxicity, indicating protein-specific KD activity rather than solely the cytotoxicity of the materials. Our polythiophene copolymers should serve as novel, efficient, low cell toxicity, and label-free siRNA delivery systems.
Collapse
Affiliation(s)
- Pan He
- Nano Medical Engineering Laboratory, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - Kyoji Hagiwara
- Nano Medical Engineering Laboratory, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - Hui Chong
- Responsive Organic Materials Laboratory, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| | - Hsiao-hua Yu
- Responsive Organic Materials Laboratory, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
- Institute of Chemistry, Academia Sinica, 128 Academic Road, Section 2, Nankang, Taipei 11529, Taiwan
| | - Yoshihiro Ito
- Nano Medical Engineering Laboratory, RIKEN, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan
| |
Collapse
|
36
|
Sugawara S, Oizumi S, Minato K, Harada T, Inoue A, Fujita Y, Maemondo M, Yoshizawa H, Ito K, Gemma A, Nishitsuji M, Harada M, Isobe H, Kinoshita I, Morita S, Kobayashi K, Hagiwara K, Kurihara M, Nukiwa T. Randomized phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations: NEJ005/TCOG0902. Ann Oncol 2015; 26:888-894. [DOI: 10.1093/annonc/mdv063] [Citation(s) in RCA: 87] [Impact Index Per Article: 9.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/21/2014] [Accepted: 02/02/2015] [Indexed: 12/13/2022] Open
|
37
|
Miyauchi E, Inoue A, Kobayashi K, Maemondo M, Sugawara S, Oizumi S, Isobe H, Gemma A, Saijo Y, Yoshizawa H, Hagiwara K, Nukiwa T. Efficacy of chemotherapy after first-line gefitinib therapy in EGFR mutation-positive advanced non-small cell lung cancer--data from a randomized Phase III study comparing gefitinib with carboplatin plus paclitaxel (NEJ002). Jpn J Clin Oncol 2015; 45:670-6. [DOI: 10.1093/jjco/hyv054] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2014] [Accepted: 03/24/2015] [Indexed: 11/13/2022] Open
|
38
|
Han B, Tjulandin S, Hagiwara K, Normanno N, Wulandari L, Konstantin Konstantinovich L, Hudoyo A, Ratcliffe M, McCormack R, Reck M. Determining the Prevalence of EGFR Mutations in Asian and Russian Patients (PTS) with Advanced Non-Small-Cell Lung Cancer (ANSCLC) of Adenocarcinoma (ADC) and Non-Adc Histology: Ignite Study. Ann Oncol 2015. [DOI: 10.1093/annonc/mdv050.01] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
39
|
Reck M, Hagiwara K, Han B, Tjulandin S, Grohe C, Yokoi T, Morabito A, McCormack R, Ratcliffe M, Normanno N. Investigating the Utility of Circulating-Free Tumour-Derived Dna (CTDNA) in Plasma for the Detection of Epidermal Growth Factor Receptor (EGFR) Mutation Status in European and Japanese Patients (PTS) with Advanced Non-Small-Cell Lung Cancer (ANSCLC): Assess Study. Ann Oncol 2015. [DOI: 10.1093/annonc/mdv128.03] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
40
|
Nakayama N, Hagiwara K, Ito Y, Ijiro K, Osada Y, Sano KI. Superior cell penetration by a rigid and anisotropic synthetic protein. Langmuir 2015; 31:2826-2832. [PMID: 25710086 DOI: 10.1021/la504494x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
Molecules with structural anisotropy and rigidity, such as asbestos, demonstrate high cell-penetrating activity but also high toxicity. Here we synthesize a biodegradable, rigid, and fibrous artificial protein, CCPC 140, as a potential vehicle for cellular delivery. CCPC 140 penetrated 100% of cells tested in vitro, even at a concentration of 3.1 nM-superior to previously reported cell-penetrating peptides. The effects of cell-strain-dependency and aspect ratio on the cell-penetrating activity of CCPC 140 were also investigated.
Collapse
Affiliation(s)
- Norihisa Nakayama
- Graduate School of Environmental Symbiotic System Major and ‡Department of Innovative Systems Engineering, Nippon Institute of Technology , Miyashiro, Saitama 345-8501, Japan
| | | | | | | | | | | |
Collapse
|
41
|
Niikura K, Kobayashi K, Takeuchi C, Fujitani N, Takahara S, Ninomiya T, Hagiwara K, Mitomo H, Ito Y, Osada Y, Ijiro K. Amphiphilic gold nanoparticles displaying flexible bifurcated ligands as a carrier for siRNA delivery into the cell cytosol. ACS Appl Mater Interfaces 2014; 6:22146-54. [PMID: 25466488 DOI: 10.1021/am505577j] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Abstract
The nanoparticle-based delivery of siRNA with a noncationic outermost surface at a low particle concentration is greatly desired. We newly synthesized a bifurcated ligand (BL) possessing hydrophobic and hydrophilic arms as a surface ligand for gold nanoparticles (AuNPs) to allow siRNA delivery. The concept underlying the design of this ligand is that amphiphilic property should allow AuNPs to permeate the cell cytosol thorough the endosomal membrane. BLs and quaternary cationic ligands were codisplayed on 40 nm AuNPs, which were subsequently coated with siRNA via electrostatic interaction. The number of siRNAs immobilized on a single nanoparticle was 26, and the conjugate showed a negative zeta potential due to siRNAs on the outermost surface of the AuNPs. Apparent gene silencing of luciferase expression in HeLa cells was achieved at an AuNP concentration as low as 60 pM. Almost no gene silencing was observed for AuNPs not displaying BLs. To reveal the effect of the BL, we compared the number of AuNPs internalized into HeLa cells and the localization in the cytosol between AuNPs displaying and those not displaying BLs. These analyses indicated that the role of BLs is not only the simple promotion of cellular uptake but also involves the enhancement of AuNPs permeation into the cytosol from the endosomes, leading to effective gene silencing.
Collapse
Affiliation(s)
- Kenichi Niikura
- Research Institute for Electronic Science (RIES), Hokkaido University , Kita 21, Nishi 10, Kita-ku, Sapporo, Hokkaido 001-0021, Japan
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
42
|
Ishimoto O, Oizumi S, Minato K, Harada T, Inoue A, Fujita Y, Maemondo M, Yoshizawa H, Ito K, Gemma A, Nishitsuji M, Harada M, Isobe H, Kinoshita I, Morita S, Kobayashi K, Hagiwara K, Kurihara M, Nukiwa T. Randomized Phase Ii Study of Concurrent Versus Sequential Alternating Gefitinib and Chemotherapy in Previously Untreated Non-Small Cell Lung Cancer (Nsclc) with Sensitive Egfr Mutations: Nej005/Tcog0902. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu349.63] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
43
|
Kikuchi Y, Okamoto T, Ogata K, Hagiwara K, Umesaki T, Kenjo M, Komune S, Tobimatsu S. P529: Abnormal auditory synchronization in stuttering: a magnetoencephalographic study. Clin Neurophysiol 2014. [DOI: 10.1016/s1388-2457(14)50627-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
44
|
Tanimizu N, Shuda A, Imanishi T, Akazawa C, Hayashi Y, Hagiwara K. The Existence of Experience and Frequency and Severity of Related Concerns of Ethical Issues in Nursing Practice Encountered in Organ Transplantation. Transplant Proc 2014; 46:1029-31. [DOI: 10.1016/j.transproceed.2013.11.079] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2013] [Accepted: 11/22/2013] [Indexed: 11/28/2022]
|
45
|
Kobayashi K, Niikura K, Takeuchi C, Sekiguchi S, Ninomiya T, Hagiwara K, Mitomo H, Ito Y, Osada Y, Ijiro K. Enhanced cellular uptake of amphiphilic gold nanoparticles with ester functionality. Chem Commun (Camb) 2014; 50:1265-7. [DOI: 10.1039/c3cc48532c] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
Gold nanoparticles (AuNPs) coated with ester-headed or ether-headed PEG ligands were synthesized.
Collapse
Affiliation(s)
- Kenya Kobayashi
- Nano Medical Engineering Laboratory
- RIKEN
- Saitama 351-0198, Japan
| | - Kenichi Niikura
- Research Institute for Electronic Science (RIES)
- Hokkaido University
- Sapporo 001-0021, Japan
| | - Chie Takeuchi
- Research Institute for Electronic Science (RIES)
- Hokkaido University
- Sapporo 001-0021, Japan
| | - Shota Sekiguchi
- Graduate School of Chemical Sciences and Engineering
- Hokkaido University
- Sapporo 060-8628, Japan
| | - Takafumi Ninomiya
- Department of Anatomy 1
- Sapporo Medical University School of Medicine
- Sapporo 060-8556, Japan
| | - Kyoji Hagiwara
- Nano Medical Engineering Laboratory
- RIKEN
- Saitama 351-0198, Japan
| | - Hideyuki Mitomo
- Research Institute for Electronic Science (RIES)
- Hokkaido University
- Sapporo 001-0021, Japan
| | - Yoshihiro Ito
- Nano Medical Engineering Laboratory
- RIKEN
- Saitama 351-0198, Japan
| | - Yoshihito Osada
- Nano Medical Engineering Laboratory
- RIKEN
- Saitama 351-0198, Japan
| | - Kuniharu Ijiro
- Research Institute for Electronic Science (RIES)
- Hokkaido University
- Sapporo 001-0021, Japan
| |
Collapse
|
46
|
Matsubara E, Okiyama S, Inokuma S, Onishi K, Nakachi S, Asashima H, Wakabayashi K, Hagiwara K, Kobayashi S. THU0055 Interstitial pneumonitis associated with rheumatoid arthritis is more prevalent in aged male with a higher RF level, and frequently combined with emphysema. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.2020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
47
|
Higuchi H, Gondaira S, Iwano H, Hirose K, Nakajima K, Kawai K, Hagiwara K, Tamura Y, Nagahata H. Mycoplasma species isolated from intramammary infection of Japanese dairy cows. Vet Rec 2013; 172:557. [PMID: 23457142 DOI: 10.1136/vr.101228] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Affiliation(s)
- H Higuchi
- Animal Health Laboratory, School of Veterinary Medicine, Rakuno Gakuen University, Animal Health Lab, Bunkyodai Midori 582, Ebetsu, Hokkaido 069-8501, Japan.
| | | | | | | | | | | | | | | | | |
Collapse
|
48
|
Sasaki Y, Hagiwara K, Kakisaka M, Yamada K, Murakami T, Aida Y. Importin α3/Qip1 is involved in multiplication of mutant influenza virus with alanine mutation at amino acid 9 independently of nuclear transport function. PLoS One 2013; 8:e55765. [PMID: 23383277 PMCID: PMC3559588 DOI: 10.1371/journal.pone.0055765] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2012] [Accepted: 01/04/2013] [Indexed: 01/06/2023] Open
Abstract
The nucleoprotein (NP) of influenza A virus is transported into the nucleus via the classical importin α/β pathway, and proceeds via nuclear localization signals (NLSs) recognized by importin α molecules. Although NP binds to importin α isoforms Rch1, Qip1 and NPI-1, the role of each individual isoform during the nuclear transport of NP and replication of the influenza virus remains unknown. In this study, we examined the contribution of importin α isoforms for nuclear localization of NP and viral growth using a panel of NP mutants containing serial alanine replacements within an unconventional NLS of NP. Alanine mutation at amino acid 8 (R8A) caused a significant reduction in the nuclear localization and binding to the three importin isoforms. The R8A NP mutant virus did not generate by reverse-genetics approach. This indicates that position 8 is the main site that mediates nuclear localization via interactions with Rch1, Qip1 and NPI-1, and subsequent viral production. This was confirmed by the finding that the conservation of amino acid 8 in human- and avian-origin influenza virus NP was necessary for virus propagation. By contrast, another mutant, S9A NP, which localized in the nucleus, caused a reduction in viral growth and vRNA transcription, suggesting that the unconventional NLS within NP may be associated with nuclear transport, vRNA transcription and viral replication through independent pathways. Interestingly, the N-terminal 110-amino acid region, which contained the unconventional NLS with S9A mutation, mainly bound to Qip1. Furthermore, activities of vRNA transcription and replication of S9A NP mutants were decreased by silencing Qip1 in without changing nuclear localization, indicating that Qip1 involves in multiplication of S9A mutant virus independently of nuclear transport function. Collectively, our results demonstrate the unconventional NLS within NP might have the additional ability to regulate the viral replication that is independent of nuclear localization activity via interactions with Qip1.
Collapse
Affiliation(s)
- Yutaka Sasaki
- Viral Infectious Diseases Unit, RIKEN, Wako, Saitama, Japan
| | - Kyoji Hagiwara
- Viral Infectious Diseases Unit, RIKEN, Wako, Saitama, Japan
| | | | - Kazunori Yamada
- Viral Infectious Diseases Unit, RIKEN, Wako, Saitama, Japan
- Laboratory of Viral Infectious Diseases, Department of Medical Genome Sciences, Graduate School of Frontier Science, The University of Tokyo, Wako, Saitama, Japan
| | - Tomoyuki Murakami
- Viral Infectious Diseases Unit, RIKEN, Wako, Saitama, Japan
- Laboratory of Viral Infectious Diseases, Department of Medical Genome Sciences, Graduate School of Frontier Science, The University of Tokyo, Wako, Saitama, Japan
| | - Yoko Aida
- Viral Infectious Diseases Unit, RIKEN, Wako, Saitama, Japan
- Laboratory of Viral Infectious Diseases, Department of Medical Genome Sciences, Graduate School of Frontier Science, The University of Tokyo, Wako, Saitama, Japan
- * E-mail:
| |
Collapse
|
49
|
Goto K, Satouchi M, Ishii G, Nishio K, Hagiwara K, Mitsudomi T, Whiteley J, Donald E, McCormack R, Todo T. An evaluation study of EGFR mutation tests utilized for non-small-cell lung cancer in the diagnostic setting. Ann Oncol 2012; 23:2914-2919. [PMID: 22776705 DOI: 10.1093/annonc/mds121] [Citation(s) in RCA: 90] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
BACKGROUND Epidermal growth factor receptor (EGFR) mutation is predictive for the efficacy of EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer (NSCLC) treatment. We evaluated the performance, sensitivity, and concordance between five EGFR tests. MATERIALS AND METHODS DNA admixtures (n = 34; 1%-50% mutant plasmid DNA) and samples from NSCLC patients [116 formalin-fixed paraffin-embedded (FFPE) tissue, 29 matched bronchofiberscopic brushing (BB) cytology, and 20 additional pleural effusion (PE) cytology samples] were analyzed. EGFR mutation tests were PCR-Invader, peptide nucleic acid-locked nucleic acid PCR clamp, direct sequencing, Cycleave, and Scorpion Amplification Refractory Mutation System (ARMS). Analysis success, mutation status, and concordance rates were assessed. RESULTS All tests except direct sequencing detected four mutation types at ≥1% mutant DNA. Analysis success rates were 91.4%-100% (FFPE) and 100% (BB and PE cytology), respectively. Inter-assay concordance rates of successfully analyzed samples were 94.3%-100% (FFPE; kappa coefficients: 0.88-1.00), 93.1%-100% (BB cytology; 0.86-1.00), and 85.0%-100% (PE cytology; 0.70-1.00), and 93.1%-96.6% (0.86-0.93) between BB cytology and matched FFPE. CONCLUSIONS All EGFR assays carried out comparably in the analysis of FFPE and cytology samples. Cytology-derived DNA is a viable alternative to FFPE samples for analyzing EGFR mutations.
Collapse
Affiliation(s)
- K Goto
- Division of Thoracic Oncology, National Cancer Center Hospital East, Chiba.
| | - M Satouchi
- Department of Thoracic Oncology, Hyogo Cancer Center, Hyogo
| | - G Ishii
- Pathology Division, Innovative Medical Research Center, National Cancer Center Hospital East, Chiba
| | - K Nishio
- Department of Genome Biology, Kinki University School of Medicine, Osaka
| | - K Hagiwara
- Department of Respiratory Medicine, Saitama Medical University, Saitama
| | - T Mitsudomi
- Department of Thoracic Surgery, Aichi Cancer Center Hospital, Aichi, Japan
| | - J Whiteley
- Department of Personalised Healthcare and Biomarkers, AstraZeneca Pharmaceuticals, Macclesfield, UK
| | - E Donald
- Department of Personalised Healthcare and Biomarkers, AstraZeneca Pharmaceuticals, Macclesfield, UK
| | - R McCormack
- Department of Personalised Healthcare and Biomarkers, AstraZeneca Pharmaceuticals, Macclesfield, UK
| | - T Todo
- Department of Research and Development, AstraZeneca KK, Osaka, Japan
| |
Collapse
|
50
|
Minegishi Y, Kobayashi K, Maemondo M, Inoue A, Sugawara S, Ohizumi S, Isobe H, Hagiwara K, Morita S, Nukiwa T, Gemma A. Prognostic Factors in Non-Small-Cell Lung Cancer (NSCLC) Patients with Epidermal Growth Factor Receptor (EGFR) Mutations: Data from the Randomized Phase III Study Compared Gefitinib with Carboplatin Plus Paclitaxel (NEJ002). Ann Oncol 2012. [DOI: 10.1016/s0923-7534(20)32317-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
|